Notice: Fall 2017 exams affected by natural disasters... More >

Expand/Collapse Close

ABIM knows that we have many physicians whose lives have been upended by recent natural disasters. If you live or work near an affected area, we understand that the weather may have impacted your ability to take your Fall 2017 exam as scheduled. We have developed a series of options to help you get through this process as smoothly as possible. If you have any questions, please call us at 1-800-441-ABIM (2246) or email request@abim.org.

American Board of Internal Medicine home page

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Board of Directors

Patricia M. Conolly, MD, Chair

Dr. Conolly is an Associate Executive Director of The Permanente Medical Group (TPMG) and the Executive Vice President for IT for the Permanente Federation. In her current role, she oversees laboratory services in Kaiser Permanente’s Northern California region and leads TPMG’s technology group, which includes development, oversight and support of technology tools to assist its members and clinicians in transforming and optimizing health care delivery. In addition, she oversees health education and health promotion in Kaiser Permanente Northern California.

Dr. Conolly is a fellow of the American College of Physicians. She served as Secretary of the Board of Directors of the American Board of Internal Medicine (ABIM), and is now its Chair. She previously served as a member of the ABIM Internal Medicine Board Exam Committee.

Dr. Conolly is a graduate of the University of San Francisco. She received her medical degree from the University of California, Los Angeles, and served on the clinical faculty at the University of California, San Francisco School of Medicine.

As of January 2017, Dr. Conolly reported no external relationships.

Marianne M. Green, MD, Chair-Elect

Dr. Green, board certified in internal medicine, is Senior Associate Dean for Medical Education at the Northwestern University Feinberg School of Medicine.

Over the course of her career, she has led several education initiatives, most recently as Administrative Leader for the Competency-Based Education Initiative, and has received numerous awards and honors, including the Harvard Macy Fellowship for Assessment in Medical Education and the George H. Joost Outstanding Teacher Award. Dr. Green is also an inaugural member of the Feinberg Academy of Medical Educators. In addition to her academic roles, Dr. Green directs patient care at the outpatient General Internal Medicine Clinic. She has authored multiple papers related to undergraduate medical education, and is a reviewer for several medical journals.

Dr. Green serves as Chair-Elect of American Board of Internal Medicine (ABIM)'s Board of Directors. She is a member of the ABIM Council and previously served as Council Director. She is also a former Chair of the ABIM Internal Medicine Board. Dr. Green is on the Liebman Scholarship Selection Committee for Northwestern University.

She received her medical degree from the University of Illinois, Chicago School of Medicine and went on to complete her internship and residency at Beth Israel Hospital, Harvard Medical School.

As of January 2017, Dr. Green reported no external relationships.

David L. Coleman, MD, Secretary

Dr. Coleman, a board certified internist and infectious diseases specialist, is the John Wade Professor and Chair of the Department of Medicine at the Boston University School of Medicine and Physician-in-Chief at Boston Medical Center. He has had a long-standing interest in basic mechanisms of macrophage function and the role of cytokines in regulating host defenses. His recent work has focused on medical professionalism in medical education and clinical practice.

Prior to assuming his current position, Dr. Coleman was Chief of Medical Service at the VA Connecticut Healthcare System and Interim Chair of the Department of Medicine at Yale University School of Medicine.

He serves on the Board of Trustees of the Boston Medical Center, on the Board of Directors of the Faculty Practice Plan of Boston Medical Center and Boston University School of Medicine, and is a member of the Executive Committee at Boston University School of Medicine. Dr. Coleman is a fellow of the American College of Physicians. He also serves as an at-large member of the Council of the Association of Professors of Medicine. Dr. Coleman serves as Secretary on the Board of Directors of the American Board of Internal Medicine (ABIM), and is also a member of the ABIM Internal Medicine Board Exam Committee.

A graduate of Stanford University, Dr. Coleman completed his medical degree at the University of California at San Francisco. He was a resident and fellow in the Department of Internal Medicine at Yale University and Yale-New Haven Hospital, where he also served as Chief Resident.

As of April 2017, Dr. Coleman reported the following external relationships.

Dr. Coleman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Association of Professors of Medicine, serving as an at-large Board Member, receiving reimbursement for travel expenses.
  • Alliance for Academic Internal Medicine, serving on the Association of Professors of Medicine Council, Member Services Committee, receiving reimbursement for travel expenses.
  • Boston University/Boston Medical Center, serving on the BMC Board of Trustee and the BU/BMC Faculty Practice Foundation Board of Directors, receiving no compensation.
  • Boston Medical Center Insurance Captive, serving on the Board of Directors, receiving reimbursement for travel expenses.

Dr. Coleman also conducted a single review of the Department of Medicine at East Carolina University in 2016, receiving honoraria and reimbursement for travel expenses.

Sonia A. Madison, MS, Treasurer

Ms. Madison served as Senior Vice President for Public Policy for AmeriHealth Mercy Family of Companies (AMFC). In this role, she was responsible for establishing the AMFC public policy agenda. Ms. Madison and her team monitored and evaluated health policy developments and trends, helping to establish AMFC's strategic direction and advocating for policies and programs that would benefit members.

Ms. Madison previously served as AMFC's interim Chief Executive Officer for LaCare, the Louisiana expansion plan. She played a critical role in working with policy makers, state government and the provider community and stakeholders to successfully implement the Louisiana line of business.

Ms. Madison served as Senior Advisor to the Secretary, U.S. Department of Health and Human Services. In this role, she had responsibility and authority to represent Secretary Leavitt in the redesign and rebuild of the Louisiana health care system with primary focus on the greater New Orleans area. Prior to this role, she served as Senior Vice President, Sales and Marketing for AmeriChoice, a UnitedHealth Group company. Prior to that, she was Chief Executive Officer for AmeriChoice of Pennsylvania, Inc. Prior to her role with AmeriChoice, Ms. Madison served as the Regional Administrator of the Centers for Medicare & Medicaid Services, Philadelphia regional office, where she was responsible for oversight of regional office operations, as well as guiding and coordinating policies for the Medicare, Medicaid and State Children's Health Insurance Programs. Before that, she was President and Chief Executive Officer of Health Partners, a managed care organization serving the Medicare and Medicaid population in Philadelphia.

With more than 30 years of health care and management experience to her credit, Ms. Madison is regarded as a leader in the health care field. Her knowledge of federal and state health care programs and policy is coupled with a keen focus on quality of care, access to services for underserved populations, outreach and education to the provider community. She is currently a member of the American Board of Internal Medicine Board of Directors.

Ms. Madison received a bachelor's degree in human services from Antioch University and a master's degree from Drexel University in Philadelphia.

As of January 2017, Ms. Madison reported no external relationships.

Richard J. Baron, MD, President & CEO

Dr. Baron, board certified in Internal Medicine and Geriatrics, is President and Chief Executive Officer of the American Board of Internal Medicine and the ABIM Foundation. Dr. Baron was a former Chair of the American Board of Internal Medicine's Board of Directors and served on the ABIM Foundation Board of Trustees.

Previously, Dr. Baron served as Group Director of Seamless Care Models at the Centers for Medicare & Medicaid Services (CMS) Innovation Center, where he led efforts related to accountable care organizations and primary care. Prior to his CMS appointment, Dr. Baron practiced general internal medicine and geriatrics for almost 30 years at Greenhouse Internists, P.C., located in Philadelphia. Greenhouse was a pioneer in the comprehensive adoption of electronic health records in the small-practice environment. Until joining the federal government, Dr. Baron also served on the board of the National Quality Forum and their Health Information Technology Advisory Committee, as well as the Standards Committee of the National Committee for Quality Assurance.

Dr. Baron served as Chief Medical Officer of Health Partners, a not-for-profit Medicaid HMO set up by four teaching hospitals in Philadelphia, from 1988 to 1996. He was the architect of the Best Clinical and Administrative Practices program, funded by the Robert Wood Johnson Foundation and the Center for Health Care Strategies, working with medical leadership of Medicaid health plans around the country in learning collaboratives to improve the quality of care for their members. This program reached plans serving more than half of the Medicaid managed care population in the United States.

Dr. Baron received an English degree from Harvard College and his medical degree from Yale University. He completed house staff training at New York University-Bellevue Medical Center and served a three-year obligation in the National Health Service Corps in rural Tennessee.

As of January 2017, Dr. Baron reported no external relationships.

Vineet Arora, MD

Dr. Arora, a board certified internist, is an academic hospitalist, Assistant Dean of Scholarship & Discovery, and Director of Graduate Medical Education Clinical Learning Environment and Innovation at University of Chicago. In the latter role, she bridges educational and hospital leadership to integrate residents and fellows into the quality, safety and value missions of the institution. Through the Agency for Healthcare Research & Quality, National Institutes of Health and ABIM Foundation funding, she has developed and evaluated novel interventions that combine systems change with adult learning theory to improve care and learning in teaching hospitals. She has authored more than 100 peer-reviewed publications, with coverage in The New York Times, NPR and the Associated Press.

As the Director of Educational Initiatives at Costs of Care, she co-chaired the Teaching Value and Choosing Wisely® Challenge and co-authored Understanding Value-Based Healthcare. For her work, she has received the American College of Physicians Walter J. McDonald Young Physician Award, the Society of Hospital Medicine's Excellence in Hospital Medicine Research Award and the Society of General Internal Medicine's Fred Brancati Leadership and Mentorship Award. In 2011, she was named to 20 People Who Make American Healthcare Better by HealthLeaders Magazine. She is a member of the American Board of Internal Medicine Board of Directors.

Dr. Arora earned her medical degree at the Washington University in St. Louis and completed her residency, chief residency and master's degree in public policy at the University of Chicago. Dr. Arora regularly tweets about medical education, technology and health policy at @futuredocs.

As of May 2017, Dr. Arora reported the following external relationships:

Work as an author with royalties or other compensation from the following companies.

  • Royalties from McGraw-Hill for the book Understanding Value-Based Care.
  • Royalties from UpToDate.

Dr. Arora serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Society of Hospital Medicine, serving as Deputy Social Media Editor, Journal of Hospital Medicine, receiving honoraria.
  • Agency for Healthcare Research and Quality (AHRQ), receiving honoraria for service as an advisory board member for AHRQ's Patient Safety Network (PSNet) and Morbidity and Mortality Rounds on the Web (Web M&M).

Dr. Arora receives funding from the following:

  • ABIM Foundation, receiving funding from the Costs of Care, paid to the University of Chicago.
  • Accreditation Council for Graduate Medical Education, receiving funding through the Pursuing Excellence in Clinical Learning Environments Initiative to transform graduate medical education to promote exemplary clinical learning environments.
  • American Medical Association, receiving funding to promote curricular change in value, improvement, safety, team training and advocacy for Pritzker School of Medicine.

Roger W. Bush, MD

Dr. Bush, a board certified internist, is the Founding Program Director of the Billings Clinic Internal Medicine Residency, the first of its kind in this vast, rural, underserved area. He is a master of the American College of Physicians (ACP) and a senior fellow in hospital medicine (Society of Hospital Medicine). His core professional interest is the design and implementation of waste-free, highly reliable clinical microsystems around the needs and preferences of patients, with clinical education and quality improvement integrated in the daily work. As Founding Program Director of the Billings Clinic Internal Medicine Residency, Dr. Bush guides its mission is to bring general internists to the region within 600 miles of Billings, Montana (Eastern Montana, Western North Dakota and Northern Wyoming).

He served as the Program Director for the internal medicine residency at Virginia Mason Medical Center from 1996-2007. He practiced primary care internal medicine for many years at Virginia Mason Medical Center in Seattle, after entering primary care practice in Newport, Oregon.

In 2011, Dr. Bush accepted ACP's appointment to the Board of Commissioners of The Joint Commission, where he chaired the Achieving High Reliability in Healthcare Strategic Interest Workgroup, and also serves on the accreditation, performance measurement and governance committees. From January 2002 to June 2009, he served on Accreditation Council for Graduate Medical Education's Residency Review Committee for Internal Medicine (RRC-IM), appointed by the ACP. He chaired the Educational Innovation Project Subcommittee of RRC-IM, a multiyear effort to change from process-based to outcomes-based accreditation and collaboratively align educational and quality of care outcomes. Dr. Bush is a member of the American Board of Internal Medicine (ABIM) Board of Directors and serves on the ABIM Internal Medicine Board.

He received his medical degree from the University of California, San Francisco, and completed internal medicine residency in 1983 at Virginia Mason Medical Center in Seattle.

As of April 2017, Dr. Bush reported the following external relationships:

Dr. Bush serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Physicians, Political Action Committee Board Member, without compensation.
  • The Joint Commission, serving on the Board of Commissioners, and as a committee Chair and committee member, receiving reimbursement for travel expenses.
  • American Board of Medical Specialties, serving as a Director of the Portfolio Board, without compensation.

Dr. Bush also reported involvement with clinical work at Neighborcare Health, a group of Federally Qualified Health Centers in Seattle.

Yul Ejnes, MD

Dr. Ejnes, a board certified internal medicine specialist, is in private practice at Coastal Medical, Inc. in Cranston, Rhode Island, which he co-founded in 1995. Coastal Medical is Rhode Island's largest private practice, a Level 3 Patient Centered Medical Home, and a Medicare accountable care organization.

In addition to practicing full-time, Dr. Ejnes is Clinical Associate Professor of Medicine at the Warren Alpert Medical School of Brown University. He is a member and past Chair of the Board of Directors of the Rhode Island Quality Institute, the state's designated regional health information organization. He is also a member of the American College of Physicians' (ACP) delegation to the American Medical Association (AMA) House of Delegates.

At ACP, Dr. Ejnes has served as Chair of the Board of Regents, Chair of the Board of Governors, Rhode Island Chapter Governor, and as member or Chair of numerous committees and task forces. He recently completed a term on the AMA Relative Value Scale Update Committee. He is a member of the American Board of Internal Medicine's Internal Medicine Board. He was also past President of the Rhode Island Medical Society and the Rhode Island Society of Internal Medicine.

Dr. Ejnes earned his medical degree from Brown Medical School in Providence, Rhode Island in 1985 and did his internal medicine residency and chief medical residency at Rhode Island Hospital, also in Providence.

As of January 2017, Dr. Ejnes reported the following external relationships:

Dr. Ejnes serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Physicians, American Medical Association House of Delegates; Coding and Payment Policy Committee; Rhode Island Chapter, Executive Council and Program Committee, receiving reimbursement for travel expenses.

Rajeev Jain, MD

Dr. Jain is a board certified gastroenterologist who has been in private practice in Dallas, Texas, since 1999. He is a partner at Texas Digestive Disease Consultants and serves as Chief of Gastroenterology at Texas Health Presbyterian Hospital in Dallas. He also is a Clinical Associate Professor of Medicine at The University of Texas Southwestern Medical School.

Dr. Jain is a member of the American Board of Internal Medicine Board of Directors. He currently serves on the American Gastroenterological Association (AGA) Governing Board as a Clinical Councilor. Prior to his current role, he served as Chair of the AGA Practice Management and Economics Committee. He has participated in clinical guideline development at both the AGA and American Society of Gastrointestinal Endoscopy (ASGE) where he served on the Standards of Practice Committee from 2008 to 2010. Additionally, Dr. Jain was a member of the task force that created the AGA colonoscopy bundle framework and was co-Director of the GI Outlook 2013 Practice Management Course co-sponsored by the AGA and ASGE. Dr. Jain is a Fellow of the American College of Physicians, AGA and ASGE.

Dr. Jain received his bachelor's degree in chemical engineering from The University of Texas at Austin and his medical degree from Baylor College of Medicine. He completed his residency training in internal medicine and fellowship in gastroenterology at The University of Texas Southwestern Medical School in Dallas, Texas.

As of January 2017, Dr. Jain reported the following external relationships:

Funding for clinical trial expenses, salary support and staff, paid to Texas Digestive Disease Consultants, from the following companies:

  • AbbVie, for a trial on induction and maintenance therapy for moderately to severely active ulcerative colitis, and for two trials on Crohn’s Disease.
  • Celgene, for trials on Crohn’s Disease.
  • Gilead, for trials on ulcerative colitis and Crohn's Disease.
  • Janssen, for a trial on induction and maintenance therapy for moderately to severely active ulcerative colitis.
  • Luitpold, for a trial on patients with iron-deficiency anemia due to irritable bowel disease or gastric bypass surgery.
  • Roche, for a trial on Crohn’s Disease and two trials on ulcerative colitis.

Dr. Jain serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Gastroenterological Association, Governing Board Member & Clinical Councilor, receiving reimbursement for travel expenses.

Dr. Jain also reported receiving reimbursement from Texas Health Resources for coordinating lectures for residents and staff.

Anand Lal, MD

Dr. Lal is board certified in Rheumatology and is the Chief of Rheumatology and Chief of Specialty Documentation and Coding for The Permanente Medical Group (TPMG), Roseville and Sacramento. He is also the Assistant Chief of Rheumatology for TPMG, Northern California and an Associate Professor (volunteer faculty) at University of California, Davis School of Medicine.

Dr. Lal has a busy rheumatology practice. Prior to training as a rheumatologist, he worked as an internist in a rural setting where he saw patients in the clinic and also took care of them when they were admitted to the hospital or ICU. He has served as the Assistant Medical Director of a large health plan and also the Assistant and Acting Medical Director of a large medical group. Before starting his residency, he worked full time as an epidemiologist.

Dr. Lal has a passion for quality improvement and the use of technology to improve patient care. He has been a member of quality improvement committees at multiple organizations. He is a member of the American Board of Internal Medicine Board of Directors. He has also played an active role in the implementation and management of Electronic Medical Records at several organizations. He is currently a part of EPIC Rheumatology Brain Trust.

Dr. Lal moved to the United States in 1991 after completing his medical school training in New Delhi, India. In addition to his post graduate training in rheumatology, Dr. Lal has a master’s in public health degree in epidemiology. He is also certified in medical management through the American Association for Physician Leadership where he is a Vanguard member.

As of January 2017, Dr. Lal reported no external relationships:

C. Seth Landefeld, MD

Dr. Landefeld is Professor and Chair, Department of Medicine, University of Alabama at Birmingham (UAB). He serves on the Boards of Directors of the UAB Health System and the University of Alabama Health Services Foundation and is a member of the U.S. Preventive Services Task Force. He is board certified in Internal Medicine.

Previously, Dr. Landefeld served as Chief of the Division of Geriatrics and Associate Chair for Strategic Planning in the Department of Medicine, University of California, San Francisco (UCSF). He also served as Associate Chief of Staff for Geriatrics and Extended Care, San Francisco VA Medical Center. He was previously Chief, Division of General Internal Medicine and Health Care Research in the Department of Medicine, Case Western Reserve University. Dr. Landefeld practiced general internal medicine and geriatrics in his previous positions; his practice is currently limited to hospital medicine.

Dr. Landefeld has developed novel approaches to improve outcomes of seriously ill older people. He and his colleagues invented Acute Care for Elders Units and demonstrated their beneficial effects for patients, families, physicians and nurses as well as on costs of care. Currently, Dr. Landefeld is a member of the American Board of Internal Medicine Board of Directors. Previously, he served as President of the Society of General Internal Medicine and on the Board of Directors of the American Geriatrics Society. He is the 2016 Laureate, Alabama Chapter, American College of Physicians and an elected member of the American Society for Clinical Investigation and the Association of American Physicians.

Dr. Landefeld received a bachelor’s degree in history and science from Harvard College and his medical degree from Yale University. He also received a bachelor’s degree in philosophy and theology from Oxford University, where he was a Rhodes Scholar. He completed house staff training at UCSF, where he served as chief medical resident, and fellowship training in general internal medicine and clinical epidemiology at Harvard Medical School and Brigham and Women's Hospital.

As of July 2017, Ms. Landefeld reported the following external relationships:

Work as an author or editor for following company, with compensation as listed:

  • McGraw-Hill, receiving compensation as an author for a chapter in geriatrics for CURRENT Medical Diagnosis and Therapy and a chapter in Current Diagnosis and Treatment: Geriatrics, 2nd edition.

Dr. Landefeld also serves on the Boards of Directors of the University of Alabama-Birmingham Health System and of the University of Alabama Health Services Foundation.

Dr. Landefeld serves on the United States Preventive Services Task Force, which is supported by the Agency for Healthcare Research and Quality, receiving reimbursement for travel expenses and honoraria for attending meetings.

Debra L. Ness, MS

Debra Ness is President of the National Partnership for Women & Families. Before assuming her current role in 2004, she served as Executive Vice President of the National Partnership for 13 years. Ms. Ness has played a leading role in positioning the organization as a powerful and effective advocate for today's women and families.

Ms. Ness is a member of the Board of Directors and chairs the Consumer Advisory Council of the National Committee for Quality Assurance. She was recently elected to serve as the first public member on the American College of Cardiology Board of Trustees and sits on the Management Board of the National Cardiovascular Data Registries. She is also one of the first public members of the American Board of Internal Medicine Board of Directors. Ms. Ness co-chairs the Consumer-Purchaser Alliance, a group of leading consumer, employer and labor organizations working to promote the use of performance measurement in health care to inform consumer choice, value-based purchasing and payment. She serves on the Executive Committee of the Health Care Transformation Task Force, and recently completed service on the Board of Directors of the National Quality Forum.

In addition, Ms. Ness serves on the Executive Committee of the Leadership Conference on Civil and Human Rights and co-chairs its Health Care Task Force. She also serves on the Board of Directors of the Economic Policy Institute.

Ms. Ness graduated summa cum laude from Drew University with a bachelor's degree in psychology and sociology. After completing graduate work in social welfare and public health policy, she received her master's degree from Columbia University School of Social Work.

As of January 2017, Ms. Ness reported the following external relationships:

Ms. Ness serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Cardiology, Board of Trustees & National Cardiovascular Data Registry Management Board Member, receiving reimbursement for travel expenses and honoraria, paid to the National Partnership for Women & Families.
  • Core Measures Collaborative, serving on the Steering Committee, receiving no compensation.
  • Health Care Payment Learning Action Network, serving on the Guiding Committee and as co-Chair of the Consumer Patient Affinity Group, receiving reimbursement for travel expenses, paid to the National Partnership for Women & Families.
  • Heath Care Transformation Task Force, serving on the Steering Committee, receiving no compensation.
  • National Committee for Quality Assurance, Board of Directors and Governance Chair and Chair of Consumer Advisory Council, receiving no compensation.

Robert D. Siegel, MD

Dr. Siegel, a board certified internist, hematologist and medical oncologist, is the Oncology Program Director for the Bon Secours St. Francis Health System in Greenville, South Carolina. Prior to his appointment to program leadership at St. Francis, Dr. Siegel had been a community-based oncologist with particular interest in quality improvement initiatives and cancer care delivery research.

Dr. Siegel has served the American Board of Internal Medicine (ABIM) as a member of the Medical Oncology Exam Writing Committee and is currently chair of its Medical Oncology Board. In July 2015, he was elected to serve on the ABIM Board of Directors. He has previously served as the co-Chair of the Quality of Care Subcommittee for the National Cancer Institute's Community Cancer Centers Program and is currently on the Executive Committee for Southeast Consortium for Oncology Research.

Dr. Siegel earned his medical degree at the Columbia University College of Physicians and Surgeons and did his internal medicine training at Barnes-Jewish Hospital/Washington University in St. Louis. He completed his fellowship training in medical oncology and hematology at the Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard University.

As of April 2017, Dr. Siegel reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Bon Secours St. Francis Hospital, from the following companies

  • Bristol-Myers Squibb, for a lung cancer clinical trial, kidney cancer clinical trial, and for a non-Hodgkin lymphoma clinical trial.
  • Cancer Insight, for a melanoma clinical trial.
  • Celgene, for two lymphoma clinical trials.
  • ImmunoGen, Phase II study of the efficacy and tolerability of IMGN529 in combination with rituximab in patients with relapsed and/or refractory diffuse large B-cell lymphomas and other non-Hodgin's lymphomas.
  • Merck, for clinical trials for head and neck carcinoma, colorectal carcinoma, breast carcinoma, lymphoma, and two stomach cancer clinical trials.
  • Mirati Therapeutics, for a clinical trial for solid tumors.
  • Onyx, for a multiple myeloma clinical trial.
  • Pharmatech, for a metastatic colon cancer clinical trial.
  • ProNAi, for a lymphoma clinical trial.
  • TG Therapeutics, for a chronic lymphocytic leukemia clinical trial.
  • Biodesix, for an observational study assessing the clinical effectiveness of validating immunotherapy tests in subject with non-small cell lung cancer.
  • CerRX Inc., for a Phase II trial of intravenous fenretinide emulsion for patients with relapsed/refractory peripheral T-cell lymphomas.
  • Boston Biomedical, for a Phase II trial of metastatic pancreatic ductal adenocarcinoma.
  • GRAIL, Inc., for a trial of use deep sequencing of circulating cell-free nucleic acids to develop assays to detect cancer early in blood.

Dr. Siegel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Society for Clinical Oncology, Chair of Quality Oncology Practice Initiative Certification Oversight Committee, Member of Maintenance of Certification Task Force, receiving reimbursement for travel expenses.
  • Dr. Siegel also serves on the Advisory Committee for Wellpoint Oncology Clinical Pathways Development, receiving reimbursement for travel expenses and honoraria for his service.